ProtAffin AG appoints Dr Mike Bartley as Chief Development Officer
Prior to joining ProtAffin, Dr. Bartley worked for 10 years at Pfizer Inc. in the UK as a Senior Project Leader for pre-clinical and clinical projects. He most recently led early clinical-stage projects in respiratory diseases at Pfizer, taking several anti-inflammatory candidates with novel mechanisms of action into the clinic. Dr. Bartley studied at Imperial College London and was awarded a PhD by Queen Mary College London, before joining ICI (Zeneca, Syngenta) agrochemicals, where he led projects in many R&D areas, several of which progressed to product launch.
Most read news
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.